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Community-wide soil-transmitted helminth treatment is 
equity-effective
Among the 20 diseases included on the WHO list 
of neglected tropical diseases, the soil-transmitted 
helminths (Ascaris lumbricoides, hookworm, and 
Trichuris trichiura) are the most prevalent (>1 billion 
people infected) and the most burdensome (global 
burden of 3 million disability-adjusted life years).1,2 At the 
turn of the new millennium, preventive chemotherapy—
the periodic administration of donated anthelmintic 
drugs to pre-school-age and school-age children—had 
been embraced as the global strategy for morbidity 
control of soil-transmitted helminths.3 In view of the 
more ambitious goals stipulated in the 2012 London 
Declaration on neglected tropical diseases, the ultimate 
target is to break transmission of soil-transmitted 
helminth infection by 2020. A comprehensive strategy, 
consisting of preventive chemotherapy at high 
population-level coverage, coupled with improvements 
in water, sanitation, and hygiene, and changes to 
risk behaviour through information, education, and 
communication might be necessary for sustainable 
control of soil-transmitted helminths.4 Furthermore, 
mathematical modelling5 and a meta-analysis6 suggest 
that community-wide treatment including all age groups 
might interrupt soil-transmitted helminth transmission.
In an Article in The Lancet, Rachel Pullan and colleagues7 
have taken this a step further. They did a large, cluster-
randomised trial, comparing three different treatment 
strategies: annual school-based intervention, treating 
all children aged 2–14 years (current standard), and 
annual or biannual community-wide treatment. They 
included 120 community units serving approximately 
150 000 households in Kenya. The primary outcome 
was community hookworm prevalence 12 months and 
24 months after treatment, and secondary outcomes 
were the prevalence of the other two soil-transmitted 
helminth species, infection intensity, equity, and cost. 
24 843 individuals were included in the assessment 
survey for the primary outcome at 12 months and 22 188 
at 24 months. Community-wide treatment was more 
effective in reducing the prevalence and intensity of 
hookworm infection compared with standard school-
based treatment (risk ratio 0∙59, 95% CI 0∙42–0∙83, 
p<0∙001), with little additional benefit of biannual 
community-wide treatment (0∙46, 0∙33–0∙63; p<0∙001). 
The authors also observed that coverage and the effects 
of the intervention in the community-wide strategy 
were equitable across demographic and socioeconomic 
subgroups.7 Therefore, community-wide treatment might 
arise as a key equity tracer for Sustainable Development 
Goal 3—that is, ensuring healthy lives and promoting 
wellbeing for all at all ages, specifically target 3.8 that 
aims at achieving universal health coverage.
We commend the authors for a well designed, timely, 
and definitive study. Together with additional evidence 
that will arise from ongoing DeWorm3 trials in Benin, 
India, and Malawi,8 this study will undoubtedly shape 
the post-2020 strategy for the control and elimination 
of soil-transmitted helminths and other neglected 
tropical diseases.
What is required before expansion and scale-up of 
preventive chemotherapy targeting soil-transmitted 
helminths? First, implementation research is still 
required to help determine the exact role of community-
wide treatment, as part of a multifaceted, intersectoral 
control strategy that will provide the necessary evidence 
on how to achieve highest benefits in reducing the 
prevalence and intensity of soil-transmitted helminth 
infection in an equity-effective manner.9 Besides 
implementation research, comparison of the costs 
of community-wide treatment and standard school-
based treatment will be important since the economic 
analysis by Pullan and colleagues was restricted to the 
community-based approaches.
Second, with regard to open issues on the treatment 
component of an integrated control package, future 
studies will need to address the effects of community-
wide treatments on A lumbricoides and T trichiura. In the 
Kenyan setting where Pullan and colleagues pursued their 
study, hookworm was the predominant soil-transmitted 
helminth species, whereas very low prevalence of 
A lumbricoides and T trichiura was observed. With regard 
to T trichiura, the authors observed no difference in the 
prevalence and intensity by treatment group. Each soil-
transmitted helminth species has distinct epidemiological 
features and age-dependent patterns of infection 
prevalence (maximum prevalence of A lumbricoides 
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and T trichiura is usually attained in young children, 
whereas the peak prevalence of hookworm is observed 
in adolescence or early adulthood),10 reinfection rates, 
and differing sensitivity to albendazole,11 which could 
influence the effects of different treatment strategies. Of 
note, hookworm infection intensity was low; therefore, 
findings from the current study are not generalisable 
to other, higher infection intensity settings. Although 
considerably more expensive, future studies should 
consider use of higher sensitivity PCR-based diagnostics, 
providing more accurate prevalence estimates compared 
with the Kato-Katz method,12 particularly when used 
on a single stool sample, as done in this study. Because 
hookworm eggs disintegrate within 1 h on Kato-
Katz thick smears, quality control is restricted to the 
other soil-transmitted helminth species,13 a diagnostic 
dilemma that can be overcome by PCR.
Third, considerable concern that expansion of anthel-
mintic drug coverage might trigger the development and 
spread of resistance exists. Albendazole and mebendazole 
are widely used in preventive chemotherapy against soil-
transmitted helminths, and evidence from veterinary 
medicine suggests that resistance developed quickly.14 
Since the optimal treatment dosage of albendazole has yet 
to be established in different age groups, underdosing—
especially in the adult population—is an issue that would 
compound the risk of drug resistance development. 
Hence, a pressing need exists for control programmes 
to routinely monitor drug efficacy to promptly discover 
the development of drug resistance. The use of drug 
combinations (eg, albendazole and ivermectin), instead of 
albendazole or mebendazole alone, would not only delay 
the development of drug resistance but also broaden the 
spectrum of activity, particularly against T trichiura and 
Strongyloides stercoralis infections and should, therefore, 
be considered the treatment of choice.14
Fourth, we need to investigate whether platforms 
are readily available that extend treatment beyond 
the schools, such as to health centres or to the 
community. Experiences and lessons from community-
wide treatments of other neglected tropical diseases 
(eg, lymphatic filariasis, onchocerciasis, and trachoma) 
must be considered. Moreover, whether pharmaceutical 
companies will be able to meet increasing drug supply 
demands remains to be seen. Finally, careful consideration 
should be given to attitudes and practices when treating 
entire communities to achieve high treatment coverage. 
Although high coverage was observed in this study using 
a unique partnership model,7 whether similarly high 
coverage can be achieved during routine programmatic 
activities, as observed elsewhere in sub-Saharan Africa,15 
warrants rigorous monitoring.
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